CAS: 6719-21-7; 2-Amino-2-Cyanoacetamide

该化合物是一种多功能化学中间体,其特点是双功能结构,其特点是与乙酰胺骨柱相连的氨基和西诺组,该化合物在有机合成中特别宝贵,作为三环化合物,如丙酰胺和三亚胺的前体,其反应能用于制药,农用化学品和特殊化学制造,核本性(氨基)和电精性(西诺)功能的存在,允许多种衍生,有利于建造复杂的分子框架,高纯度可满足严格的研究和工业要求,建议适当处理,因为其可能具有湿度和热度敏感性.

结构式图片

相似化合物

62009-47-6 35320-22-0 7324-05-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号32683-02-6 2-氨基-2-氰基乙酸乙酯 | CAS号7440-06-4 铂 | CAS号105-34-0 氰乙酸甲酯 | CAS号127745-39-5 2-cyano-2-oximi... | CAS号89765-49-1 ethyl (E)-2-cya... | CAS号144-55-8 碳酸氢钠 | CAS号3849-20-5 2-氰基-2-(羟基亚氨基)乙酰胺 | CAS号360-97-4 5-氨基-4-甲酰胺咪唑 | CAS号5539-46-8 5-胺基噻唑-4-甲酰胺 | CAS号127574-36-1 5-amino-1-benzh... | CAS号14056-39-4 N2-乙酰基-3-次氮基丙氨酰胺 | CAS号34407-35-7 2-cyano-2-(1-et... | CAS号64995-55-7 5-amino-1-pheny... | CAS号52868-71-0 5-amino-2-(meth... | CAS号3815-69-8 5-amino-1-benzy... | CAS号37800-98-9 5-氨基-2-甲基-1H-咪唑-4-羧胺 | CAS号37642-55-0 1H-Imidazole-4-...

合成工艺路线路线简述

  • 合成目标产物 2-Amino-2-Cyanoacetamide 主要起始原料 Ethyl 2-Amino-2-Cyanoacetate Oxalate H2O
  • (文献来源)合成步骤主要原料 Ethyl 2-Amino-2-Cyanoacetate Oxalate H2O
Nitrosocyanoacetamide置于铂 氢气体系中,用 甲醇,水,异丙醇 作为反应溶剂,以1%的收率获得产物2-氨基-2-氰基乙酰胺
参考文献:Method Of Producing Aminocyanoacetamide
标题:Method Of Producing Aminocyanoacetamide
摘要:通过目前的方法,首次可以在工业上应用的过程可用于直接生产氨基氰乙酰胺.该方法基于氰乙酰胺与亚硝酸盐在约ph 2的条件下反应形成亚硝基氰乙酰胺,然后通过催化氢化将亚硝基氰乙酰胺转化为氨基氰乙酰胺.

海关参考信息

专利信息


专利号:US-7737284-B2
优先权日:2001-01-18
标题 :Synthesis of temozolomide and analogs
发明人:KUO SHEN-CHUN; MAS JANET L; HOU DONALD CHEN-TUNG
权利人:SCHERING PLOUGH CORP
摘要:This invention relates to a novel process for the synthesis of Temozolomide, an antitumor compound, and analogs, and to intermediates useful in this novel process.

专利号:US-6849735-B1
优先权日:2000-06-23
标 题:Methods of synthesis for 9-substituted hypoxanthine derivatives
发明人:GLASKY ALVIN J; BOLLINGER HEINRICH; MUELLER HANS RUDOLF
权利人:MERCK EPROVA AG
摘要:An improved method of synthesis of a 9-substituted hypoxanthine derivative comprises the steps of: (1) reacting aminocyanacetamide with triethyl orthoformate to form an imidoester derivative of aminocyanacetamide; (2) forming a compound having a reactive amino group on a hydrocarbyl moiety, the hydrocarbyl moiety being linked through an amide group to a physiologically active moiety or an esterified derivative of a physiologically active moiety including therein an esterified benzoyl group; (3) reacting the imidoester with the compound having the reactive amino group on the hydrocarbyl moiety to form a derivative of aminoimidazole-4-carboxamide substituted at the 1-position with a hydrocarbyl moiety linked through an amide group to a physiologically active moiety including therein an optionally esterified benzoyl group; (4) forming the six-membered heterocyclic ring of the purine moiety of the hypoxanthine by reacting the derivative of 5-aminoimidazole-4-carboxamide formed in step (3) with triethyl orthoformate to form a 9-substituted hypoxanthine compound substituted at the 9-position with a hydrocarbyl moiety linked through an amide group to a physiologically active moiety including therein an optionally esterified benzoyl group; and (5) hydrolyzing the ester of the optionally esterified benzoyl group if present.

专利号:US-2002156277-A1
优先权日:2001-04-20
标题 :Synthesis and methods of use of purine analogues and derivatives
发明人:FICK DAVID B; FOREMAN MARK M; GLASKY ALVIN J
摘要:A purine derivative or analogue comprises a 9-atom bicyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y 1 )—D, where Y 1 can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption or blood-brain barrier penetration of the derivative or analogue. The moiety A has a six-membered ring fused to a five-membered ring. The moiety A can have one, two, or three nitrogen atoms in the five membered ring and has two nitrogen atoms in the six-membered ring. The moiety A can be a purine moiety. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.

专利号:US-2005131227-A1
优先权日:2001-01-18
标 题:Synthesis of temozolomide and analogs

专利号:US-2006229456-A1
优先权日:2001-01-18
标 题:Synthesis of Temozolomide and analogs

专利号:WO-02057269-A1
优先权日:2001-01-18
标题:Synthesis of temozolomide and analogs
南京新斯特生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.nstbio.com
企业联系电话:025-85331029,18915981017👤
📞南京新斯特生物科技有限公司 ⚠️参考联系方式
联系人:杨女士
电话:025-85331029,18915981017
手机:18915981017
传真:025-85331829
邮箱:sales@nstbio.com
通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
邮编: 210010
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Grimmett, M. R., Science of Synthesis, (2002) 12, 344.
摘要:Grimmett, M. R., Science of Synthesis, (2002) 12, 426.
摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 669.
摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 672.
摘要:Sato, N., Science of Synthesis, (2004) 16, 771.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知